AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Big pharma #Biopharma #Biotechnology #Covid-19 #Drug development #Drug discovery

Waters CEO explains how analytical technologies can assist drug discovery

Udit Batra, CEO of Waters, is known as a listener, learner and gatherer of facts. He talks to Lu Rahman about Waters’ collaboration with pharma and biopharma companies to accelerate vaccine and therapy development as well as the company’s new data analysis technology. LR: We know that the last year… Read More

#Exclusive Content #News

#AI / data analytics / healthtech / informatics #Bioentrepreneur #Biologics / Biotechnology #Biotechnology

Tech lets bioentrepreneurs run start-ups from coffee shops

Scispot.io, a life science digitisation and automation company, has launched a digital operating platform for life science leaders and scientists which will allow entrepreneurs to start and virtually run their biotech startups from garages, coffee shops or anywhere innovation is born. The company’s mission is to create a digital life… Read More

#News #Start-up Zone

#AI / data analytics / healthtech / informatics #Drug discovery

Why collaboration matters and how to make it a success

Drug discovery is complex and the expertise it requires is vast. Matthew A. Clark, Chief Executive Officer, X-Chem, talks to Lu Rahman about the company’s experience of collaboration and how it enables innovation, flexibility and problem-solving. Drug discovery is the most interdisciplinary of all scientific endeavours, says Clark. “To successfully… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Diabetes #Drug development #Precision medicine

The power of precision medicine

Listen to this article on the DDW Podcast: Lu Rahman looks at the role precision medicine is playing in how we approach the patient and the way we  treat disease. We hear increasingly about the shift away from one size fits all medicine. It does of course, make perfect sense and… Read More

#Editor's Choice #Exclusive Content #Intelligence #News #Trends & Analysis

#AI #AI / data analytics / healthtech / informatics #Cancer research #Drug design #Drug development #Drug discovery

First AI-designed immuno-oncology drug enters clinical trials

Exscientia, an artificial intelligence (AI)-driven pharmatech company, has announced the first AI-designed molecule for immuno-oncology to enter human clinical trials, a joint venture co-invented and developed by Exscientia and Evotec. The A2a receptor antagonist, which is in development for adult patients with advanced solid tumours, includes the application of Exscientia’s… Read More

#Cancer Research #News

#AI #AI / data analytics / healthtech / informatics #Drug discovery #Research

Charles River and Valence partner to provide AI-enabled drug design

Charles River Laboratories and Valence Discovery have teamed up to provide clients access to Valence’s artificial intelligence platform for molecular property prediction, generative chemistry, and multiparameter optimisation. Building on research done by Valence’s founding team at Mila, a deep learning research institute, the Valence platform enables the design of small… Read More

#News

#AI #AI / data analytics / healthtech / informatics #Automation / robotics #Drug discovery

Meet Ulysses, the fully automated drug discovery platform

Welcome to the Future of Drug Discovery. Welcome to Arctoris from Arctoris on Vimeo. Arctoris is a global platform company headquartered in Oxford, UK that is transforming drug discovery by combining robotics and AI. Arctoris developed and operates Ulysses, a fully automated drug discovery platform. Ulysses… Read More

#News #Videos

#AI / data analytics / healthtech / informatics #Clinical trial #Drug efficacy #Regulatory

Novadiscovery collaborate with Takeda for new clinical simulation

Novadiscovery (NOVA), a health tech company offering JINKO, a clinical trial simulation platform to predict drug efficacy and optimise clinical trial development, has announced its new collaboration with Takeda Pharmaceutical. This is aimed at incorporating clinical simulation technology on virtual patients into Takeda France’s access strategy and building on an… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trial #Data #Drug development #Drug discovery #Report

Report promotes the use of synthetic data in clinical trials

Phesi, provider of AI-powered clinical development analytics products and solutions, and Accenture, a services and consulting company, have released the first of a series of reports exploring the use of synthetic data in clinical development. In recent years, the volume of data created through clinical trials and electronic patient records… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Finance #Pharmatech

$100 million invested in AI development

Clinical pharmatech company Exscientia’s Series C financing round was completed with investment of $30 million from BlackRock, which will accelerate its AI drug discovery platform and pipeline. Blackrock funds joined Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital in the investment $100 million round. New capital will be… Read More

#News

#AI / data analytics / healthtech / informatics #Chromatography #Drug discovery

Waters and TetraScience partner to deliver access and insights for chromatography data

Waters Corporation has entered a reseller agreement with TetraScience, a cloud technology innovator for life sciences R&D. Through the partnership, Waters will offer its customers the Empower Data Science Link, powered by TetraScience. This technology pairs Waters’ compliance-ready Empower Chromatography Data System (CDS) with TetraScience’s Data Platform and data science… Read More

#News

#AI / data analytics / healthtech / informatics #Cell therapy #Cold chain

Cytiva and Brooks Life Sciences enhance automation in cold chain solutions

Cytiva and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to integrate Brooks Life Sciences BioStore III automated storage platform. This has been purpose built to handle a range of high value materials between the temperatures of -20°C and -190°C in… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Drug discovery #Pharmaceuticals #Rare disease #Therapeutics

The move towards patient-powered, data-driven rare disease drug discovery

By Rayne Rodgers, Vice President and Executive Director of MOVR for Muscular Dystrophy Association (MDA), and Sharon Hesterlee MDA’s Executive Vice President and Chief Research Officer. As an umbrella organisation representing those living with more than 40 types of neuromuscular disorders, the Muscular Dystrophy Association (MDA) contributes significantly to innovations… Read More

#Editor's Choice #Exclusive Content #News

#AI / data analytics / healthtech / informatics #Drug discovery #Therapeutics

Exscientia and University of Oxford partner on AI-driven Alzheimer’s treatments

Exscientia, an AI drug discovery company, has announced its collaboration with the Alzheimer’s Research UK University of Oxford Drug Discovery Institute (ARUK-ODDI) to develop medicines targeting neuroinflammation for the treatment of Alzheimer’s disease (AD). AD is the most common form of dementia worldwide, with an estimated 44 million people living… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Drug discovery

Optibrium investment will boost computer-aided drug discovery

Optibrium, developer of software for drug discovery, has raised significant investment from Kester Capital, a private equity firm typically. The funding  should accelerate the development of the business through organic growth and acquisition. Currently, more than 150 organisations worldwide deploy Optibrium’s technology in their research programs, including five of the… Read More

#News

#AI / data analytics / healthtech / informatics #Drug development #Drug discovery #Gene therapy #Life sciences #Narrated podcasts #Stem cells

The power of precision and the potential of human tissue chips

Today’s episode is titled: The power of precision and the potential of human tissue chips, and covers 2 articles taken from the most recent issue of DDW. These articles are titled: The power of precision to keep biologics effective and safe & Why we should be interested in human tissue chips These… Read More

#Podcasts